This material is sold for laboratory research use only
(2011) examined the effects of BPC-157 on rats subjected to diclofenac-induced toxicity, which typically causes significant gastrointestinal, liver, and brain lesions
At TOSM, we take a whole-body approachso if a patient shows signs of gut-related symptoms impacting performance or recovery, we may consider this added benefit when recommending peptides
In addition, there is a similarity between the changes in the expression of 45 genes one hour after either GABA or Selank is given, which is practically identical
The honest read for any runner thinking about peptides because an injury wont quit: the animal data is interesting, the human data is thin, the supply chain isnt safe, and the boring standard treatments with decades of human trials behind them still work